STK26 and metabolic dysfunction-associated steatotic liver disease: Our earlier studies demonstrated that hepatic MST4 expression positively correlates with the severity of human MASLD and that the in vitro silencing of MST4 in human hepatocytes markedly suppresses lipotoxicity triggered by exposure to fatty acids [18,22].